Zeeshan Ateeb
Karolinska University Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zeeshan Ateeb.
European Journal of Human Genetics | 2016
Jessica Becker; Stephan L. Haas; Anna Mokrowiecka; Justyna Wasielica-Berger; Zeeshan Ateeb; Jonna Bister; Peter Elbe; Marek L. Kowalski; Magdalena Gawron-Kiszka; Marek Majewski; Agata Mulak; Maria Janiak; Mira M. Wouters; Till Schwämmle; Timo Hess; Lothar Veits; Stefan Niebisch; José L. Santiago; Antonio Ruiz de León; Julio Pérez de la Serna; Elena Urcelay; Vito Annese; Anna Latiano; Uberto Fumagalli; Riccardo Rosati; Luigi Laghi; Rosario Cuomo; Frank Lenze; Giovanni Sarnelli; Michaela Müller
Idiopathic achalasia is a severe motility disorder of the esophagus and is characterized by a failure of the lower esophageal sphincter to relax due to a loss of neurons in the myenteric plexus. Most recently, we identified an eight-amino-acid insertion in the cytoplasmic tail of HLA-DQβ1 as strong achalasia risk factor in a sample set from Central Europe, Italy and Spain. Here, we tested whether the HLA-DQβ1 insertion also confers achalasia risk in the Polish and Swedish population. We could replicate the initial findings and the insertion shows strong achalasia association in both samples (Poland P=1.84 × 10−04, Sweden P=7.44 × 10−05). Combining all five European data sets – Central Europe, Italy, Spain, Poland and Sweden – the insertion is achalasia associated with Pcombined=1.67 × 10−35. In addition, we observe that the frequency of the insertion shows a geospatial north–south gradient. The insertion is less common in northern (around 6–7% in patients and 2% in controls from Sweden and Poland) compared with southern Europeans (~16% in patients and 8% in controls from Italy) and shows a stronger attributable risk in the southern European population. Our study provides evidence that the prevalence of achalasia may differ between populations.
Hpb | 2018
Marco Del Chiaro; Elena Rangelova; Asif Halimi; Zeeshan Ateeb; Chiara Scandavini; R. Valente; Ralf Segersvärd; Urban Arnelo; Caroline S. Verbeke
BACKGROUND Few studies have investigated the outcome of pancreatectomy associated with artery resection (PAR). METHODS Retrospective analysis of a cohort of operated borderline or locally advanced pancreatic cancer patients with surgically confirmed arterial involvement. Short and long-term outcome were analyzed and compared in patients who underwent PAR (Group 1) and palliative surgery (Group 2). RESULTS Of 73 patients who underwent surgical exploration with intent of resection, 34 underwent PAR (±venous resection) (Group 1) and 39 underwent palliation (Group 2). 23 patients (67.7%) in Group 1 underwent combined artery-vein resection (AVR). Operation time was longer and blood loss higher in group 1 compared to group 2. There were no differences in post-operative mortality (2.9% vs 2.6%, p = 0.9) and post-operative surgical complications (38.2% vs 25.6%, p = 0.2). The 1, 3 and 5 years survival in Group 1 was superior to Group 2 (63.7%, 23.4% and Q3 23.4% vs 41.7%, 3.2% and 0, p = 0.003). CONCLUSION PAR seems to be safe and feasible in well selected patients and associated with an advantage of survival compared to palliation, in patients affected by locally advanced pancreatic cancer.
Annals of Pancreatic Cancer | 2018
Roberto Valente; Urban Arnelo; Marcus Reuterwall Hansson; Zeeshan Ateeb; Elena Rangelova; Matthias Lohr; Marco Del Chiaro
Background: Current management of main duct (MD)involving intraductal papillary mucinous neoplasm (IPMN) is driven by intra-operative frozen section. However, data regarding the clinical utility of this approach are discordant. In fact, frozen section of pancreatic resection margin can’t detect skip lesions within MPD and this might imply incomplete resections and short term recurrences after resection. Peroral pancreatoscopy is a promising tool to investigate the MPD but is technically highly skill demanding and therefore difficult to use on a large scale. The application of intraoperative pancreatoscopy might be able to bypass this problem but data about its safety are currently lacking. This study aims to assess the safety of intraoperative pancreatoscopy. Methods: Retrospective cohort analysis of patients undergoing surgical resection for MD-involving IPMN. All indications for surgery were decided according to the European Guidelines for the management of pancreatic cystic tumors. Data about characteristics of patients, type of surgery, mortality and length of hospital stay, overall complications and procedure related preoperative complications (pancreatitis, perforations) were recorded. Results: From 2015 to 2016 22 patients, 10 (45%) male, median age 67 (45–82 years) underwent surgical resection for MD-involving IPMN and intraoperative pancreatoscopy. Overall complications were reported in 9 (40%) of patients. 1 patient (4.5%) underwent reoperation for incisional hernia, 1 (4.5%) developed pancreatic fistula, 2 (9%) had GI bleeding requiring endoscopy. None of the patients developed procedure related morbidity and mortality. The mean length of hospital stay was 15.36 days. Conclusions: Intraoperative pancreatoscopy in the investigation of IPMN patients with dilated MPD is a feasible and safe procedure.
Annals of Surgical Oncology | 2017
Marco Del Chiaro; Zeeshan Ateeb; Marcus Reuterwall Hansson; Elena Rangelova; Ralf Segersvärd; Nikolaos Kartalis; Christoph Ansorge; Matthias Lohr; Urban Arnelo; Caroline S. Verbeke
Annals of Pancreatic Cancer | 2018
Marco Del Chiaro; Elena Rangelova; Asif Halimi; Zeeshan Ateeb; Chiara Maria Scandavini; Roberto Valente; Lars Lundell; Ralf Segersvärd; Urban Arnelo
Annals of Pancreatic Cancer | 2018
Robin Kivila; Roberto Valente; Elena Rangelova; Asif Halimi; Zeeshan Ateeb; Chiara Maria Scandavini; Ralf Segersvärd; Urban Arnelo; Marco Del Chiaro
Annals of Pancreatic Cancer | 2018
Rogier Gaiser; Haleh Davanian; Hassan Alkharaan; Carlos Fernández Moro; Zeeshan Ateeb; Marco Del Chiaro; Margaret Chen
Annals of Pancreatic Cancer | 2018
Roberto Valente; Urban Arnelo; Marcus Reuterwall Hansson; Zeeshan Ateeb; Miroslav Vujasinovic; Asif Halimi; Chiara Maria Scandavini; Matthias Lohr; Marco Del Chiaro
Pancreatology | 2017
Elena Rangelova; Roberto Valente; Chiara Maria Scandavini; Zeeshan Ateeb; Asif Halimi; Rafaella Pozzi-Mucelli; Urban Arnelo; Marco Del Chiaro
Pancreatology | 2017
Urban Arnelo; Roberto Valente; Markus Reuterwall; Magnus Konradsson; Zeeshan Ateeb; Elena Rangelova; Matthias Löhr; Marco Del Chiaro